{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:11:15Z","timestamp":1782922275178,"version":"3.54.5"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Sentinel lymph node mapping (SLNM) using 99mTc-nanocolloid single photon emission tomography\/computed tomography (SPECT\/CT) is a minimally invasive technique for detecting lymphatic metastasis in early-stage endometrial cancer. This study aimed to evaluate the detection rate (DR) of sentinel lymph nodes (SLNs) using SPECT\/CT and compare the findings with intraoperative gamma probe evaluation and histopathological results.<\/jats:p><jats:p>\n          Methods\u2003A retrospective cohort study was conducted at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia, between December 2022 and January 2024. Twenty-six patients with FIGO (International Federation of Gynecology and Obstetrics) stage I endometrial cancer were included. 99mTc-nanocolloid was injected into four cervical quadrants, followed by SPECT\/CT imaging and intraoperative gamma probe evaluation. Histopathological analysis was performed to confirm the presence of metastasis.<\/jats:p><jats:p>\n          Results\u2003SLNs were detected in 20 patients (76.9%) using SPECT\/CT, with 100% concordance with gamma probe findings. Histopathological analysis identified metastasis in four patients (15.4%). Tumor size was significantly associated with SLN detection (p\u2009&lt;\u20090.001), with larger tumors (&gt; 4\u2009cm) more frequently associated with positive SLNs. However, no significant correlation was found between SPECT\/CT maximum counts and histopathological metastasis (p: 0.156). Among the six patients with negative SPECT\/CT findings, all patients underwent lymphadenectomy, and no metastasis was detected in these cases.<\/jats:p><jats:p>\n          Conclusion\u2003SPECT\/CT using 99mTc-nanocolloid is an effective tool for SLNM in early-stage endometrial cancer, demonstrating a high DR and perfect concordance with intraoperative gamma probe findings. Its superior anatomical accuracy enhances surgical planning. Tumor size significantly influences SLN detection, with larger tumors being more frequently associated with positive SLNs. However, SPECT\/CT count intensity does not correlate with histopathological metastasis.<\/jats:p>","DOI":"10.1055\/s-0045-1805095","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:16:41Z","timestamp":1741825001000},"page":"161-165","source":"Crossref","is-referenced-by-count":2,"title":["Detection of Sentinel Lymph Node in Endometrial Cancer Using 99mTc-Nanocolloid SPECT\/CT: A Retrospective Cohort Study"],"prefix":"10.1055","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9224-8965","authenticated-orcid":false,"given":"Raydel BrianKwee","family":"Amalo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Theranostic Moleculer, School of Medicine, Universitas Padjajaran, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endah","family":"Indriani","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Theranostic Moleculer, School of Medicine, Universitas Padjajaran, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendra","family":"Budiawan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Theranostic Moleculer, School of Medicine, Universitas Padjajaran, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budi","family":"Darmawan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Theranostic Moleculer, School of Medicine, Universitas Padjajaran, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basuki","family":"Hidayat","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Theranostic Moleculer, School of Medicine, Universitas Padjajaran, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155","author":"M Koskas","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"A Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"ref3","volume-title":"Recent Advances in Endometrial Cancer","author":"M Sumita","year":"2020"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-95564-3","volume-title":"Nuclear Medicine Textbook: Methodology and Clinical Applications","author":"D Volterrani","year":"2019"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5603\/NMR.a2022.0022","article-title":"Preoperative detection of sentinel lymph node in patients with endometrial cancer - comparison of planar lymphoscintigraphy, spect and SPECT\/CT","volume":"25","author":"A Jankulovska","year":"2022","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s00259-021-05404-1","article-title":"G. Mariani, S. Vidal-Sicart, R.A. Valdes Olmos (Eds): Atlas of Lymphoscintigraphy and Sentinel Node Mapping, Second Edition","volume":"48","author":"M Sicignano","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"R L Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri","volume":"95","author":"W T Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","first-page":"8584130","article-title":"Age at menopause and risk of developing endometrial cancer: a meta-analysis","volume":"2019","author":"Y Wu","year":"2019","journal-title":"BioMed Res Int"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2010.09.001","article-title":"Endometrioid carcinoma of the endometrium: pathologic and molecular features","volume":"27","author":"A Azueta","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/ijgc-2022-004073","article-title":"Endometrial carcinosarcoma","volume":"33","author":"G Bogani","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"ref13","volume-title":"Hormonal Pathology of the Uterus","author":"W E Crusio","year":"2020"},{"key":"ref14","volume-title":"Female Genital Tumours","author":"World Health Organization (WHO)","year":"2020","edition":"5th ed."},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crad.2006.06.015","article-title":"Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis","volume":"62","author":"S A Sohaib","year":"2007","journal-title":"Clin Radiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"881850","DOI":"10.3389\/fonc.2022.881850","article-title":"Association of tumor size with myometrial invasion, lymphovascular space invasion, lymph node metastasis, and recurrence in endometrial cancer: a meta-analysis of 40 studies with 53,276 patients","volume":"12","author":"X Jin","year":"2022","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"701758","DOI":"10.3389\/fonc.2021.701758","article-title":"Sentinel lymph node mapping in endometrial cancer: a comprehensive review","volume":"11","author":"L Zhai","year":"2021","journal-title":"Front Oncol"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s12885-017-3671-0","article-title":"Whether intermediate-risk stage 1A, grade 1\/2, endometrioid endometrial cancer patients with lesions larger than 2\u2009cm warrant lymph node dissection?","volume":"17","author":"M Zhu","year":"2017","journal-title":"BMC Cancer"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/1097-0142(19910601)67:11<2791::AID-CNCR2820671113>3.0.CO;2-S","article-title":"Tumor size in endometrial cancer","volume":"67","author":"J C Schink","year":"1991","journal-title":"Cancer"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s40064-016-1720-9","article-title":"Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study","volume":"5","author":"N La Verde","year":"2016","journal-title":"Springerplus"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4048\/jbc.2021.24.e4","article-title":"Relation between tumor size and lymph node metastasis according to subtypes of breast cancer","volume":"24","author":"S K Min","year":"2021","journal-title":"J Breast Cancer"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s43055-022-00716-0","article-title":"Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET\/CT: role of metabolic tumor volume and total lesion glycolysis","volume":"53","author":"M M Abdelkawi","year":"2022","journal-title":"Egypt J Radiol Nucl Med"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1805095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:38:04Z","timestamp":1746571084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1805095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":21,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,5,6]]},"published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1805095","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}